Last updated on November 2017

A Phase 3 Double-Blind, Placebo-Controlled Study to assess the efficacy, safety and tolerability of NKTR-181 In Opioid-Naïve subjects with moderate to severe chronic low back pain.


Brief description of study

A Phase 3 Double-Blind, Placebo-Controlled Study to assess the efficacy, safety and tolerability of NKTR-181 In Opioid-Naïve subjects with moderate to severe chronic low back pain.

Detailed Study Description

This study is being conducted to evaluate the safety and effectiveness of a study drug for the treatment of chronic low back pain. If you qualify for participation in this study, your participation would last approximately 25 weeks and you would be required to make about 20 office visits to our clinic. As a qualified participant you will be compensated $50 per visit. Also, as a participant in the study you will receive study medication or placebo, physical exams, lab tests, and other medical tests as necessary for the completion of this study, at no cost to you.

Clinical Study Identifier: TX7330

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Arizona Research Center

Arizona Research Center
Phoenix, AZ USA
  Connect »